Legal Representation
Attorney
John J McDonnell
USPTO Deadlines
Application History
15 eventsDate | Code | Type | Description |
---|---|---|---|
Dec 30, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Feb 5, 2003 | EX4G | S | SOU EXTENSION 4 GRANTED |
Nov 20, 2002 | EXT4 | S | SOU EXTENSION 4 FILED |
Jun 26, 2002 | EX3G | S | SOU EXTENSION 3 GRANTED |
May 20, 2002 | I | PAPER RECEIVED | |
May 20, 2002 | EXT3 | S | SOU EXTENSION 3 FILED |
Dec 3, 2001 | EX2G | S | SOU EXTENSION 2 GRANTED |
Nov 20, 2001 | EXT2 | S | SOU EXTENSION 2 FILED |
May 30, 2001 | EX1G | S | SOU EXTENSION 1 GRANTED |
May 18, 2001 | EXT1 | S | SOU EXTENSION 1 FILED |
Nov 21, 2000 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Aug 29, 2000 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 28, 2000 | NPUB | O | NOTICE OF PUBLICATION |
Jun 1, 2000 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 30, 2000 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
Pharmaceutical preparations for anti-angiogenic therapy, including cancer treatment
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...